Les publications

Page en cours de mise à jour... Retrouvez ici les publications des équipes de recherche du CGO

375 publications
Année de publication :
Réseaux :

The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on…

Although some studies suggested that disruption of the Hippo signaling pathway is associated with osteosarcoma progression, the molecular mechanisms by which YAP regulates primary tumor growth is not fully clarified.

  • Ref: Cancers (Basel). 2020 Dec 20;12(12):3847.
  • Année de publication : 2020
  • Auteurs : Morice S, Mullard M, Brion R, Dupuy M, Renault S, Tesfaye R, Brounais-Le Royer B, Ory B, Redini F, Verrecchia F.
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs » & « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Recurrence Pattern of Cervical Cancer Based on the Platinum Sensitivity Concept: A Multi-Institutional Study from the…

The standard of care for patients with advanced cervical cancer (ACC) includes platinum-based chemotherapy. The concept of platinum sensitivity is a major prognostic factor for patients with ovarian cancer.

  • Ref: J Clin Med. 2020 Nov 12;9(11):3646.
  • Année de publication : 2020
  • Auteurs : de Foucher T, Hennebert C, Dabi Y, Ouldamer L, Lavoué V, Dion L, Canlorbe G, Bolze PA, Golfier F, Akladios C, Lecointre L, Kerbage Y, Collinet P, Bricou A, Carcopino X, Huchon C, Raimond E, Graesslin O, Owen C, Touboul C, Ballester M, Darai E, Bendifallah S.
  • Réseaux : Réseaux: « Immunothérapies »
Lire la publication

Accuracy of peritoneal carcinomatosis extent diagnosis by initial FDG PET CT in epithelial ovarian cancer: A…

Peritoneal carcinomatosis extent in ovarian cancer is difficult to evaluate by imaging techniques even though it determines the surgical complexity and survival. The aim of this study was to estimate the accuracy of 2-[18F]-fluoro-2-deoxy-d-glucose (FDG)-PET CT (Positron-emission tomography coupled with Computerised Tomography) performed before any treatment, in the diagnosis of the extent of peritoneal carcinomatosis.

  • Ref: J Gynecol Obstet Hum Reprod. 2020 Nov;49(9):101867.
  • Année de publication : 2020
  • Auteurs : Delvallée J, Rossard L, Bendifallah S, Touboul C, Collinet P, Bricou A, Huchon C, Lavoue V, Body G, Ouldamer L.
  • Réseaux : Réseaux: « Immunothérapies »
Lire la publication

Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis.

In most autoimmune disorders, crosstalk of B cells and CD4 T cells results in the accumulation of autoantibodies. In autoimmune hepatitis (AIH), the presence of anti-soluble liver antigen (SLA) autoantibodies is associated with reduced overall survival, but the associated autoreactive CD4 T cells have not yet been characterised.

  • Ref: J Hepatol. 2020 Dec;73(6):1379-1390.
  • Année de publication : 2020
  • Auteurs : Renand A, Cervera-Marzal I, Gil L, Dong C, Garcia A, Kervagoret E, Aublé H, Habes S, Chevalier C, Vavasseur F, Clémenceau B, Cardon A, Judor JP, Mosnier JF, Tanné F, Laplaud DA, Brouard S, Gournay J, Milpied P, Conchon S.
  • Réseaux : Réseaux: « Immunothérapies »
Lire la publication

Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells.

Anti-PD1 immunotherapy, as a single agent or in combination with standard chemotherapies, has significantly improved the outcome of many patients with cancers. However, resistance to anti-PD1 antibodies often decreases the long-term therapeutic benefits.

  • Ref: Cell Death Dis. 2020 Dec 11;11(12):1048.
  • Année de publication : 2020
  • Auteurs : Guyon, N., Garnier, D., Briand, J., Nadaradjane, A., Bougras-Cartron, G., Raimbourg, J., Campone, M., Heymann, D., Vallette, F. M., Frenel, J. S., & Cartron, P. F.
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs »
Lire la publication

DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple…

Multiple myeloma (MM) is a heterogeneous plasma cell malignancy that remains challenging to cure. Global hypomethylation correlates with an aggressive phenotype of the disease, while hypermethylation is observed at particular regions of myeloma such as B cell-specific enhancers.

  • Ref: Clin Epigenetics. 2020 Nov 2;12(1):163.
  • Année de publication : 2020
  • Auteurs : Alberge JB, Magrangeas F, Wagner M, Denié S, Guérin-Charbonnel C, Campion L, Attal M, Avet-Loiseau H, Carell T, Moreau P, Minvielle S, Sérandour AA.
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs »
Lire la publication

Sarcoma treatment in the era of molecular medicine.

Sarcomas are heterogeneous and clinically challenging soft tissue and bone cancers. Although constituting only 1% of all human malignancies, sarcomas represent the second most common type of solid tumors in children and adolescents and comprise an important group of secondary malignancies.

  • Ref: EMBO Mol Med. 2020 Nov 6;12(11):e11131.
  • Année de publication : 2020
  • Auteurs : Grünewald TG, Alonso M, Avnet S, Banito A, Burdach S, Cidre-Aranaz F, Di Pompo G, Distel M, Dorado-Garcia H, Garcia-Castro J, González-González L, Grigoriadis AE, Kasan M, Koelsche C, Krumbholz M, Lecanda F, Lemma S, Longo DL, Madrigal-Esquivel C, Morales-Molina Á, Musa J, Ohmura S, Ory B, Pereira-Silva M, Perut F, Rodriguez R, Seeling C, Al Shaaili N, Shaabani S, Shiavone K, Sinha S, Tomazou EM, Trautmann M, Vela M, Versleijen-Jonkers YM, Visgauss J, Zalacain M, Schober SJ, Lissat A, English WR, Baldini N, Heymann D.
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs »
Lire la publication

EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell…

The role of Epigenetics in Epithelial Mesenchymal Transition (EMT) has recently emerged. Two epigenetic enzymes with paradoxical roles have previously been associated to EMT, EZH2 (Enhancer of Zeste 2 Polycomb Repressive Complex 2 (PRC2) Subunit), a lysine methyltranserase able to add the H3K27me3 mark, and the histone demethylase KDM6B (Lysine Demethylase 6B), which can remove the H3K27me3 mark.

  • Ref: Cancers (Basel). 2020 Dec 5;12(12):3649.
  • Année de publication : 2020
  • Auteurs : Lachat C, Bruyère D, Etcheverry A, Aubry M, Mosser J, Warda W, Herfs M, Hendrick E, Ferrand C, Borg C, Delage-Mourroux R, Feugeas JP, Guittaut M, Hervouet E, Peixoto P.
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs »
Lire la publication

Involvement of GPx-3 in the Reciprocal Control of Redox Metabolism in the Leukemic Niche.

The bone marrow (BM) microenvironment plays a crucial role in the development and progression of leukemia (AML). Intracellular reactive oxygen species (ROS) are involved in the regulation of the biology of leukemia-initiating cells, where the antioxidant enzyme GPx-3 could be involved as a determinant of cellular self-renewal.

  • Ref: Int J Mol Sci. 2020 Nov 14;21(22):8584.
  • Année de publication : 2020
  • Auteurs : Vignon C, Debeissat C, Bourgeais J, Gallay N, Kouzi F, Anginot A, Picou F, Guardiola P, Ducrocq E, Foucault A, Ravalet N, Le Nail LR, Domenech J, Béné MC, Le Bousse-Kerdilès MC, Gyan E, Herault O.
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs »
Lire la publication